University of California San Francisco Give to UCSF

Please join us for a discussion with global health experts on the use of monoclonal antibodies to fight COVID-19 in Africa. While the world has mobilized at unprecedented speed to develop effective vaccines, it will still take time for widespread vaccine distribution and immunization, particularly in the lower income countries. Complementary solutions, such as effective therapeutics, are urgently needed to mitigate the toll of the pandemic in Africa. Technologies that we develop now during the COVID-19 pandemic also have the potential to aid in future pandemics. 

Register at: https://globalhealthsciences.ucsf.edu/event/monoclonal-antibodies-covid-19-africa-promise-and-pitfalls-digital-panel-and-forum

With the recent commitment by the Bill and Melinda Gates Foundation and Eli Lilly and Company to procure monoclonal antibodies for low- and middle-income countries, there is a need to identify how, when and where these drugs should be used. Significant hurdles to effective deployment exist, including highly technical manufacturing and limited production, cold chain requirements, high prices and efficacy likely limited to specific populations.

Panelists will discuss the obstacles to efficiently, effectively, and equitably rolling out monoclonal antibodies for COVID-19 across Africa and identify possible solutions for addressing these challenges. The webinar will be hosted by the Pandemic Response Initiative at the University of California San Francisco Institute for Global Health Sciences.

Host

Professor Sir Richard Feachem, KBE, FREng, DSc(Med), PhD 
Director, Global Health Group and Professor of Global Health, Institute for Global Health Sciences, University of California San Francisco

 

Moderator

Kelly C. Sanders, MD, MS 

Technical Lead, Pandemic Response Initiative, Institute for Global Health Sciences, University of California San Francisco

 

Panelists

Bernice T. Dahn, MD, MPH 

Vice President for Health Sciences, University of Liberia

Former Minister of Health for the Republic of Liberia

 

Professor Sir Jeremy Farrar, OBE, FMedSci, FRS 

Director, Wellcome Trust

Co-Chair, Access to COVID-19 Tools Accelerator

 

Dean Pettit, PhD

Affiliate Professor, University of Washington, Bioengineering

Sr VP, Biotherapeutic Science at Just-Evotec Biologics

 

Fatima Suleman, BPharm, MPharm, PhD 

University of Kwa-Zulu Natal

World Health Organization Collaborating Centre for Pharmaceutical

 

Prashant Yadav, PhD, MBA 

Senior Fellow, Center for Global Development; Affiliate Professor, INSEAD

 

Discussant

George B. Kyei, MD, PhD, MS 

Internal Medicine and Infectious Disease Physician, University of Ghana

 

Closing Remarks

Trevor Mundel, MBBCh, PhD, MSc 

President of Global Health, Bill & Melinda Gates Foundation

Event Details

  • Robert Alan Mansfield

1 person is interested in this event